Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

SWOG 0910, A Phase II Study of Epratuzumab (NSC-716711) in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Ph-Neg


Collapse Overview 
Collapse sponsor award id
SWOG 0910


Collapse Biography 

Collapse Time 
Collapse start date
2011-02-01